Blogs

Two-year follow-up of a dose reduction strategy trial of biologics adalimumab, etanercept, and ustekinumab in psoriasis patients in daily practice

By Aesthetic Multispecialty Society posted Jan 07, 2021 09:40 AM

  
.
0 comments
0 views

Permalink